NurExone Biologic Inc. (TSXV:NRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.7050
+0.0050 (0.71%)
May 1, 2025, 9:30 AM EDT
21.55%
Market Cap 55.00M
Revenue (ttm) n/a
Net Income (ttm) -7.26M
Shares Out 78.01M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,000
Average Volume 12,390
Open 0.7050
Previous Close 0.7000
Day's Range 0.7050 - 0.7050
52-Week Range 0.4600 - 0.8700
Beta 0.02
RSI 58.27
Earnings Date May 27, 2025

About NurExone Biologic

NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.